The third annual World Anti-Microbial Resistance (AMR) Congress, being held September 14 and 15 in Washington, DC, will provide a forum to discuss the current global public health crisis of AMR, and to formulate a collaborative response to tackle all aspects of the crisis. Leaders in policy, drug development, and research will discuss these challenges, including spurring antibiotic development, and developing more efficient diagnostics solutions to improving stewardship.
William Powderly, MD, FIDSA, president of IDSA, will co-present the keynote address with American Society for Microbiology President, Susan Sharp, PhD. The address will focus on initiatives to drive legislative efforts and policies to spur antibiotic and diagnostics development and curb antimicrobial resistance. The World Anti-Microbial Resistance Congress brings together key stakeholders including industry, international organizations, academia, government, regulators, payers and centers of care, to address this multi-faceted rising public health threat.
A limited number of tickets are available to IDSA members interested in attending the meeting. Please email Jennifer Morales at firstname.lastname@example.org to request a ticket. Tickets will be distributed on a first come, first serve basis.
Next Article >